Animal studies suggest that RhoA and ROCK inhibitors, as well as ROS scavengers, could be potential strategies for preventing and treating oxygen toxicity-induced pulmonary fibrosis (Ni et al., 2013). This evidence concerns the gene RHOA and pulmonary fibrosis.